Serum N-terminal brain natriuretic peptide indicates exercise induced augmentation of pulmonary artery pressure in patients with mitral stenosis

Echocardiography

Volumn 28, Issue 1, 2011, Pages 8-14

  Kilickesmez, Kadriye Orta ^a   Ãzkan, Alev Arat ^a   Abaci, Okay ^a   Camläca, Hakan ^a   Kocas, Cuneyt ^a   Kaya, Aysem ^a   Baskurt, Murat ^a   Yiaǧit, Zerrin ^a   Kucukoaǧlu, Serdar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

brain natriuretic peptide; exercise stress echocardiography; mitral stenosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART LEFT ATRIUM; HEART RATE; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE SIZE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE STENOSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REST; STRESS ECHOCARDIOGRAPHY; SYMPTOM; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL EXERCISE; VALVULAR HEART DISEASE;

CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NATRIURETIC PEPTIDE, BRAIN; PULMONARY ARTERY;

EID: 79251499715     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2010.01273.x     Document Type: Article

References (32)

1. Bonow RO, Carabello BA, Chatterjee K, et al,: 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118: e523-661.
2. Wu WC, Aziz GF, Sadaniantz A,: The use of stress echocardiography in the assessment of mitral valvular disease. Echocardiography 2004; 21: 451-458
3. Maréchaux S, Bellouin A, Polge AS, et al,: Clinical value of exercise Doppler echocardiography in patients with cardiac-valvular disease. Arch Cardiovasc Dis 2008; 101: 351-360.
4. Mukoyama M, Nakao K, Saito Y, et al,: Human brain natriuretic peptide as a novel cardiac hormone. Lancet 1990; 335: 801-802.
5. Hunt PJ, Espiner EA, Nicholls MG, et al,: The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32. Peptides 1997; 18: 1475-1481.
6. Thibault G, Charbonneau C, Bilodeau J, et al,: Rat brain natriuretic peptide is localized in atrial granules and released into the circulation. Am J Physiol 1992; 263: 301-309.
7. Sutton TM, Stewart RA, Gerber IL, et al,: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280-2287.
8. Yusoff R, Clayton N, Keevil B, et al,: Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol 2006; 97: 1498-1501.
9. Iltumur K, Karabulut A, Yokus B, et al,: N-terminal proBNP plasma levels correlate with severity of mitral stenosis. J Heart Valve Dis 2005; 14: 735-741.
10. Arat-Ozkan A, Kaya A, Yigit Z, et al,: Serum N-terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis. Echocardiography 2005; 22: 473-478.
11. Schwammenthal E, Vered Z, Agranat O, et al,: Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis: An exercise echocardiographic study. Circulation 2000; 102: 2378-2384.
12. Song JK, Kang DH, Lee CW, et al,: Factors determining the exercise capacity in mitral stenosis. Am J Cardiol 1996; 78: 1060-1062.
13. Izgi C, Ozdemir N, Cevik C, et al,: Mitral valve resistance as a determinant of resting and stress pulmonary artery pressure in patients with mitral stenosis: A dobutamine stress study. J Am Soc Echocardiogr 2007; 20: 1160-1166.
14. Schiller NB, Shah PM, Crawford M, et al,: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
15. Martin RP, Rakowski H, Kleiman JH, et al,: Reliability and reproducibility of two dimensional echocardiograph measurement of the stenotic mitral valve orifice area. Am J Cardiol 1979; 43: 560-568.
16. Hatle L, Angelsen B, Tromsdal A,: Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 1979; 60: 1096-1104.
17. Himelman RB, Stulbarg MS, Lee E, et al,: Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced Doppler echocardiography. Am Heart J 1990; 119: 685-688.
18. Kircher BJ, Himelman RB, Schiller NB,: Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66: 493-496.
19. Yandle TG, Richards AM, Gilbert A, et al,: Assay of brain natriuretic peptide (BNP) in human plasma: Evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76: 832-838.
20. Davutoglu V, Celik A, Aksoy M, et al,: Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur J Heart Fail 2005; 7: 532-536.
21. Goetze JP, Friis-Hansen L, Rehfeld JF, et al,: Atrial secretion of B-type natriuretic peptide. Eur Heart J 2006; 27: 1648-1650.
22. Hasegawa K, Fujiwara H, Itoh H, et al,: Light and electron microscopic localization of brain natriuretic peptide in relation to atrial natriuretic peptide in porcine atrium. Immunohistocytochemical study using specific monoclonal antibodies. Circulation 1991; 84: 1203-1209.
23. Nagaya N, Nishikimi T, Okano Y, et al,: Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208.
24. Yoshimura M, Yasue H, Okumura K, et al,: Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464-469.
25. GölbaÅÄ Z, UÃar O, Yüksel AG, et al,: Plasma brain natriuretic peptide levels in patients with rheumatic heart disease. Eur J Heart Fail 2004; 6: 757-760.
26. Cheriex EC, Pieters FA, Janssen JH, et al,: Value of exercise Doppler-echocardiography in patients with mitral stenosis. Int J Cardiol. 1994; 45 (3): 219-226.
27. Leavitt JI, Coats MH, Falk RH,: Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: A Doppler echocardiographic study. J Am Coll Cardiol 1991; 17: 1520-1506.
28. Mohan JC, Mukherjee S, Kumar A, et al,: Does chronic mitral regurgitation influence Doppler pressure half-time-derived calculation of the mitral valve area in patients with mitral stenosis Am Heart J 2004; 148: 703-709.
29. Rifkin RD, Harper K, Tighe D,: Comparison of proximal isovelocity surface area method with pressure half-time and planimetry in evaluation of mitral stenosis. J Am Coll Cardiol 1995; 26: 458-465.
30. Bennis A, Drighil A, Tribouilloy C, et al,: Clinical application in routine practice of the proximal flow convergence method to calculate the mitral surface area in mitral valve stenosis. Int J Cardiovasc Imaging 2002; 18: 443-451.
31. Sagar KB, Wann LS, Paulson WJ, et al,: Role of exercise Doppler echocardiography in isolated mitral stenosis. Chest 1987; 92: 27-30.
32. Redfield MM, Rodeheffer RJ, Jacobsen SJ, et al,: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002; 40: 976-982.